Hence, in order to improve the diagnostic and treatment modalities of ADC of UC, targeted therapies with more sensitivity and specificity and the combined analysis of Cyclin D1, JAG1 and Notch-3 in ADC are required. This evidence concerns the gene JAG1 and AIDS dementia complex.